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816-3 Coxsackie-Adenovirus-Receptor Induction Is 
Associated With Enteroviral and Adenoviral Infection in 
Acute Myocarditis and Dilated Cardiomyopathy 
Michel Noutsias, Wolfgang C. Poller, Henry Fechner, Felicitas Escher, Heinz P. 
Schultheiss, Matthias Pauschinger, UKBF, Free University, Berlin, Germany 
Background: The coxsackie-adenovirus-receptor (CAR) is the common receptor for both 
cardiotropic viruses, its regulation mechanisms and biological significance, however, are 
still elusive. We previously demonstrated cardiomyocyte (CM)-CAR-induction in dilated 
cardiomyopathy (DCM). In the present work, we investigated CAR-expression in 
endomyocardial biopsies (EMBs) of acute myocarditis (AMC) and DCM patients in asso- 
ciation with cardiotropic viral infection. 
Methods: EMBs from AMC (n=l7) and DCM patients (n=i 1) were analyzed for CAR- 
expression and CD2+/CD3+ T-lymphocytic infiltrates by immunohistology and were 
quantified by digital image analysis (DIA). Viral genome was amplified by polymerase 
chain reaction. Donor hearts (n=7) served as controls. 
Results: Whereas controls demonstrated low CAR-expression levels, being confined to 
scattered interstitial and vascular smooth muscle cells (DIA-measured Area FractionlAF: 
0.00004+0.00006), CM-CAR-induction was present n=l5 (54%) of the patients EMBs 
(CAR-AF: 0.007~0.01; p<O.OOl). This was due to CM-CAR-induction in 9 (53%) of the 
AMC and in 6 (55%) of the DCM-patients, respectively, with the overall CAR-AF not 
being significantly different between both patient groups (p=O.l4). Significant CDZ+/ 
CD3+ infiltration (>7.0/mm2) was documented in n=l3 cases (45%). Enteroviral genome 
was proven in n=5 (lE%), and adenoviral in n=4 (14%) of the EMBs, respectively. CAR- 
induction was significantly associated with the presence of enteroviral (p=O.OZ) and ade- 
noviral genome (p=O.O04) and T-lymphocytic infiltration (p=O.OOl). Whereas CM-CAR- 
induction displayed a diffuse expression pattern in DCM, CM-CAR-expression was pre- 
dominantly focal, adjacent to focal lymphocytic infiltrates. 
Conclusions: Our data indicate that CM-CAR-induction is a key molecular determinant 
for the cardiotropism of both adeno- and enteroviruses in AMC and DCM. The spatial 
association between CM-CAR-expression and focal T-lymphocytes in AMC suggests 
that immunocompetent paracrine factors are involved in the regulation of CAR-gene 
expression. 
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816-4 Effect of Astragaloside on Myocardial Fibrosis in 
Murine CVB, Myocarditis 
Zhao Cai Zhang, Shuang Jie Li, Ying Zhen Yang, Hao Zhu Chen, Jun Bo Ge, Shanghai 
Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, Shanghai, 
People’s Republic of China 
Background:-This study was designed to investigate the effect of Astragaloside, the 
active component of Astragalus mongholicus Bge., on myocardial fibrosis in Coxsackie 
Virus B, (CV& ) induced murine myocarditis model. 
Methods:-BALB/C mice were divided into 5 groups: normal control (A), placebo treated 
myocarditis group (B), myocarditis treated with 1% (C),3% (D) and 9% (E) Astragaloside 
per gsvage daily for 7days (n=l5-20 in each group). Collagen volume fraction (CVF) was 
determined on picrosirius red-stained sections with an automated image analysis sys- 
tem. The receptors of INFa and 1NF-y were detected by immunohistochemistry. &opt@ 
SIS of myocytes were measured by flow cytometry. 
Result: The mortality of murines was significantly reduced in 9% Astragaloside treated 
animals than control animals in group B (10% vs 44.4%, pcO.01): CVF was significantly 
decreased in group E than that of group B (3.12r0.47% vs 5.96*0.38%, pcO.O5), while 
the survival, CVF were not affected by 1% and 3% Astragaloside. The expression of INF- 
a and INF-7 receptor increased after 3% and 9% Astragaloside treatments. Apoptosis 
index of myocytes was lower in 9% Astragaloside treated murines compared with that of 
group B (9.80*4.03%vs 41.59+8.89%, p<O.Ol). 
Conclusion : These results show that 9% Astragaloside improved survival, reduced CVF 
and apoptosis in this model. The antiviral effect of Astragaloside by upregulating INF-a 
and INF-ycould play an important role for these beneficial effects.. 
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616-5 Comparing Long-Term Survival and Frequency of Heart 
Transplantation in Patients With Suspected Versus 
Biopsy-Proven Myocarditis: A 15-Year Prospective 
Follow-Up 
Nadira Rambihar, Philip Jong, Peter R. McLaughlin, Jack Butany, Jay W. Mason, Peter 
P. Liu, Toronto General Hospital, Toronto, ON, Canada 
Background: The long-term prognosis of patients with suspected but biopsy-negative 
myocerditis compared to those with biopsy-proven myocarditis is not known. 
Methods: We prospectively followed 134 consecutive patients with suspected wral myo- 
carditis screened during the NIH Myocarditis Treatment Trial. We compared the risk- 
adjusted survival over 15 years between patients whose myocarditis was confirmed by 
endomyocardwl biopsy according to the Dallas criteria (Dallas +ve) and those whose 
biopsy did not fulfill such criteria (Dallas -ve). 
Results: Only 21 patients (16%) were Dallas +ve for myocarditis. Heart transplantation 
was required in 7% of the cohort (1 in Dallas +ve vs. 6 in Dallas -ve group, p=.70). After 
adjustments for age, sex, and ventricular grade, the 5. and lo-year transplant-free sur- 
vival rates in the Dallas -ve group were 86% and 77%, which were only marginally better 
than 62% and 70% in the Dallas we group (p=.45, Figure). Presence of endowdial or 
interstitial fibrosis and absence of muscle fiber hyperirophy were significant histopatho- 
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logic predictors of poorer survival (hazard ratio = 2.9, p=.OZ), regardless of the Dallas 
status on biopsy. 
Conclusion: Patients with suspected but biopsy-negative myocarditis according to the 
Dallas criteria had adverse 15.year survival that was only marginally better than those 
with biopsy-proven myocarditis. Current pathologic criteria may be insensitive in risk 
stratitying this subgroup previously assumed to have a benign prognosis. 
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617-l Does Isolated Diastolic Dysfunction Explain Dyspnea in 
a Population With Preserved Left Ventricular Systolic 
Function and No Signs of Lung Disease? 
Frants Pedersen, llan Raymond, Jesper Mehlsen, Dan Atar, Per Hildebrandt, 
Frederiksberg University Hospital, Copenhagen, Denmark, Aker University Hospital, 
Oslo, Norway 
Background: A substantial fraction of patients with symptoms of heart failure has pre- 
served left ventricular (LV) systolic function. Symptoms in these patients, in particular 
dyspnea, may be caused by isolated diastolic dysfunction (DD). The purpose of the study 
was to scrutinize the cause of dyspnea in a population with preserved LV systolic func- 
tion and no signs of lung disease, using a state-of-the-art work-up, and thus to assess 
the prevalence of isolated DD es the primary cause for dyspnea. 
Methods: 555 subjects aged 60-79 years recruited from the background population 
answered a heart failure questionnaire, which identified 205 (37%) subjects with dyspnea 
on exertion who were invited to participate. 150 subjects with dyspnea were examined 
with echocardiography and lung function test. Subjects without signs of lung disease 
(n=62) were further examined with MRI-scanning of the heart, ECG, chest x-ray and 
bicycle exercise test. DD was defined by tissue Doppler imaging: 1) early diastolic veloc- 
ity of the mitral annulus (Ea) ~6 cm/s, and 2) ratio of peak E wave (E) I Ea ~10. 
Results At interview, dyspnea on exertion could be confirmed in 130 out of 150 sub- 
jects. 68 subjects (53%) had signs of lung disease. In the group of patients without lung 
disease (n=62), 12 subjects had either LV systolic dysfunction, atrial fibrillation or valvu- 
lar heart disease. Other probable causes of dyspnea in the remaining group (1~50) were: 
objective signs of ischemic heart disease (n=2), body mass index 230 (n=24), and LV- 
hypertrophy (n=7). Of these 50 subjects, only 2 pts. had E/Es > 10 (4%) and 7 pts. had 
Ea c6 cm/s (14%). 21 subjects had none of the above-mentioned potential causes of 
dyspnea, and of these, none had E/Es > 10 and 3 had Ea <8 cm/s. 
Conclusion: In subjects with dyspnea without signs of lung disease, 2/3rd of the cohort 
had a potential cause of dyspnea independent of DD. The frequency of isolated DD was 
low !n the group of subjects with dyspnea and no signs of LV systolic dysfunction, atrlal 
fibrillation or valvular heart disease. Hence isolated diastolic dysfunction, es assessed by 
tissue Doppler imaging, is rarely the reason for dyspnea on exertion, when screening is 
performed in a general population segment. 
